Quantitative SARS-CoV-2 RT-PCR and Bronchoalveolar Cytokine Concentrations Redefine the COVID-19 Phenotypes in Critically Ill Patients
Cristina Vazquez Guillamet(Washington University in St. Louis), Philip A. Mudd(Washington University in St. Louis), Ali H. Ellebedy(Washington University in St. Louis), Marin H. Kollef(Washington University in St. Louis), Vladimir Despotović(Washington University in St. Louis), Derek E. Byers(Washington University in St. Louis), Bijal A. Parikh(Washington University in St. Louis), Ashraf Rjob(Regional Medical Center), Rodrigo Vazquez Guillamet(Washington University in St. Louis), Daniel Reynolds(Washington University in St. Louis)
Cited by 3
Related Papers
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
|CHEST Journal|2002|1.3k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
|Cell Host & Microbe|2021|851